# Ganoderma lucidum 'Lingzhi'

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/ganoderma-lucidum-lingzhi
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-05
**Evidence Score:** 2 / 10
**Category:** Mushroom/Fungi
**Also Known As:** Reishi mushroom, Lingzhi, Ganoderma lucidum, Red reishi, Varnish shelf, Lacquered bracket fungus, Glossy ganoderma, Mannentake, King of herbs, Mushroom of immortality, Divine mushroom, Spiritual potency mushroom

## Overview

Ganoderma lucidum 'Lingzhi' is a cultivated variant of reishi mushroom that produces ganoderic acids and [beta-glucan](/ingredients/condition/immune-support) polysaccharides, bioactive compounds studied for their interaction with immune and metabolic pathways. Current research on this specific cultivar focuses primarily on optimizing cultivation conditions for bioactive compound yield rather than documenting clinical health outcomes in humans.

## Health Benefits

• Limited evidence available - research provided focuses only on cultivation methods
• Bioactive compound production documented (ganoderic acids, polysaccharides) but no clinical outcomes reported
• No human clinical trials or health benefit data available in provided research
• No evidence quality assessments possible from cultivation studies alone
• Further clinical research needed to establish health benefits

## Mechanism of Action

Ganoderic acids, lanostane-type triterpenoids produced by Ganoderma lucidum, are proposed to inhibit HMG-CoA reductase and modulate NF-κB signaling pathways, potentially influencing [inflammatory](/ingredients/condition/inflammation) cytokine expression. [Beta-glucan](/ingredients/condition/immune-support) polysaccharides extracted from this cultivar interact with Dectin-1 and Toll-like receptor 2 (TLR-2) on macrophages and dendritic cells, theoretically activating innate immune responses. However, these mechanistic pathways have been characterized primarily in vitro and in preclinical models, and their translation to clinical outcomes in humans consuming the Lingzhi cultivar specifically has not been established in published trials.

## Clinical Summary

No human clinical trials specifically investigating the Ganoderma lucidum 'Lingzhi' cultivar have been identified in available research literature. Existing published research for this variant centers on mycological cultivation methodology, including substrate optimization and environmental conditions that maximize ganoderic acid and polysaccharide concentrations. Broader reishi mushroom research in humans exists but cannot be directly extrapolated to this cultivar without cultivar-specific bioavailability and phytochemical profiling data. The overall evidence quality for health benefit claims specific to this cultivar must be rated as insufficient pending dedicated clinical investigation.

## Nutritional Profile

Ganoderma lucidum (Lingzhi) is a low-calorie functional mushroom with a complex bioactive profile. Macronutrients per 100g dried weight: protein 10–40g (varies significantly by substrate and strain, contains all essential amino acids including lysine and leucine), carbohydrates 45–65g (predominantly as complex polysaccharides), fat 1–3g (including oleic acid, stearic acid, and ergosterol as a precursor to vitamin D2), crude fiber 15–59g (including chitin in cell walls which reduces bioavailability of some nutrients). Key bioactive compounds: beta-glucan polysaccharides 10–50g/100g dry weight (primary [immunomodulatory](/ingredients/condition/immune-support) fraction; bioavailability enhanced by hot-water extraction or alcohol tincture preparation vs. raw consumption), ganoderic acids (triterpenoids) 1–3g/100g dry weight (over 140 distinct triterpenes identified including ganoderic acids A, B, C, D, and G; fat-soluble, better absorbed with dietary fat), adenosine 0.1–0.5mg/g dry weight, and ergosterol 0.3–0.8mg/g (converted to vitamin D2 upon UV exposure). Minerals per 100g dry weight: potassium 800–1200mg, phosphorus 500–900mg, magnesium 100–200mg, calcium 20–60mg, zinc 5–10mg, iron 3–8mg, selenium 0.5–2mg (substrate-dependent). B-vitamins present including riboflavin (B2) ~0.4mg/100g and niacin (B3) ~6–8mg/100g. Bioavailability note: chitin-bound nutrients are poorly absorbed from raw or whole dried material; extraction methods (hot water for polysaccharides, ethanol for triterpenoids, or dual extraction) substantially increase bioavailability of therapeutic compounds. Cultivation substrate (wood type, sawdust composition) significantly influences final ganoderic acid and polysaccharide concentrations.

## Dosage & Preparation

No clinical dosage information available in the provided research. Studies document only production yields: ganoderic acids up to 582 mg/L, exopolysaccharides up to 3.5 g/L in fermentation cultures. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

General Ganoderma lucidum preparations have been associated with adverse effects including dry mouth, dizziness, gastrointestinal upset, and elevated liver enzymes in isolated case reports, though cultivar-specific safety data for Lingzhi is not established. Reishi mushroom compounds may potentiate anticoagulant medications such as warfarin due to platelet aggregation inhibition, and concurrent use with immunosuppressants warrants caution given proposed [immunomodulatory](/ingredients/condition/immune-support) activity. Individuals with bleeding disorders, autoimmune conditions, or scheduled surgery should consult a physician before use. Pregnancy and breastfeeding safety for this cultivar is unknown due to an absence of relevant clinical data.

## Scientific Research

The provided research contains no clinical trials, meta-analyses, or PMIDs. Available studies focus exclusively on cultivation optimization and extraction methods, with no human health outcome data or pharmacological investigations documented.

## Historical & Cultural Context

No historical or traditional use information provided in the available research. Studies focus exclusively on modern cultivation techniques and extraction methods developed for commercial production.

## Synergistic Combinations

Insufficient data - no synergistic ingredient information provided

## Frequently Asked Questions

### What is Ganoderma lucidum Lingzhi and how does it differ from regular reishi?

Ganoderma lucidum 'Lingzhi' is a specific cultivated variant of the reishi mushroom species selected or bred for particular growth characteristics or bioactive compound profiles. While it produces the same primary compounds as other reishi varieties — ganoderic acids and beta-glucan polysaccharides — cultivar-specific differences in the relative concentrations of these compounds depend heavily on substrate, temperature, and cultivation method. Direct comparative clinical data between Lingzhi and other G. lucidum cultivars in human subjects is not currently available.

### What bioactive compounds are found in Ganoderma lucidum Lingzhi?

Ganoderma lucidum Lingzhi produces lanostane-type triterpenoids collectively called ganoderic acids, as well as high-molecular-weight beta-1,3/1,6-glucan polysaccharides, which are its principal documented bioactive constituents. Research on this cultivar has specifically documented that cultivation conditions such as substrate composition and CO2 levels significantly influence the yield of these compounds. No standardized extract ratio or minimum ganoderic acid content has been established specifically for the Lingzhi cultivar in a clinical supplement context.

### Are there any human clinical trials on Ganoderma lucidum Lingzhi?

As of available published research, no human clinical trials specifically enrolling subjects and using Ganoderma lucidum 'Lingzhi' as the tested intervention have been identified. The existing peer-reviewed literature on this cultivar is focused on agricultural and mycological research, including optimizing fruiting body yield and bioactive compound concentration during cultivation. Consumers should be cautious about health claims for this specific cultivar, as they currently lack the clinical trial support present for some other reishi preparations.

### Can Ganoderma lucidum Lingzhi interact with medications?

Based on the known pharmacology of Ganoderma lucidum compounds broadly, Lingzhi preparations may carry a risk of interaction with anticoagulant drugs such as warfarin or aspirin, as ganoderic acids have demonstrated platelet aggregation inhibitory activity in preclinical studies. Polysaccharide fractions with immunomodulatory properties could theoretically counteract immunosuppressant drugs like cyclosporine, though this has not been studied for the Lingzhi cultivar specifically. Anyone taking prescription medications, particularly blood thinners or immune-modulating therapies, should consult a healthcare provider before using this supplement.

### What is the recommended dosage of Ganoderma lucidum Lingzhi?

No evidence-based dosage recommendation exists specifically for the Ganoderma lucidum 'Lingzhi' cultivar, as no human clinical trials have established an effective or safe dose range for this variant. General reishi mushroom supplements in clinical research have used doses ranging from 1.5 g to 9 g of dried mushroom equivalent per day, but these figures cannot be directly applied to Lingzhi without cultivar-specific standardization data. Until controlled trials define a dose-response relationship for this cultivar, any dosage guidance would be speculative.

### What is the difference between wild-harvested and cultivated Ganoderma lucidum Lingzhi?

Wild-harvested Lingzhi is rare and expensive, growing naturally on decaying hardwood trees, while cultivated varieties are grown on controlled substrates like wood logs or grain-based media. Cultivation methods significantly affect bioactive compound production, with different growing conditions (temperature, humidity, substrate type) influencing ganoderic acid and polysaccharide concentrations. Cultivated Lingzhi offers more consistent quality and bioactive profiles compared to the unpredictable composition of wild specimens.

### How do different cultivation methods affect the potency of Ganoderma lucidum Lingzhi?

The substrate material, growth duration, environmental conditions (light, humidity, temperature), and harvest timing all influence the concentration of bioactive compounds like ganoderic acids and polysaccharides in Lingzhi. Log-based cultivation typically produces higher-quality fruiting bodies with better bioactive profiles than grain-based methods, though grain cultivation is more cost-effective. Research on cultivation optimization shows that extended growing periods and specific environmental controls can increase medicinal compound yields compared to standard commercial production.

### Is Ganoderma lucidum Lingzhi suitable for long-term daily use as a wellness supplement?

While traditional use suggests Lingzhi is safe for prolonged consumption, human clinical trials specifically evaluating long-term safety and efficacy are lacking, limiting definitive recommendations. The available research focuses on cultivation methods rather than human health outcomes, making it difficult to establish optimal duration and frequency of supplementation. Anyone considering long-term Lingzhi use should consult a healthcare provider, particularly those with existing health conditions or taking medications.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*